FIRST ADDENDUM TO MANUFACTURING SERVICES AGREEMENTKeryx Biopharmaceuticals Inc • November 6th, 2014 • Pharmaceutical preparations
Keryx Biopharmaceuticals, Inc. (“CUSTOMER”) and Norwich Pharmaceuticals, Inc. (“NPI”) have entered into a Manufacturing Services Agreement as of January 17, 2014 (“MSA”). CUSTOMER and NPI hereby agree to revise the MSA to include the items set forth in this first addendum, dated October 24, 2014 (“First Addendum”), as follows:
Manufacturing Services Agreement January 17, 2014Manufacturing Services Agreement • November 6th, 2014 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
This MANUFACTURING SERVICES AGREEMENT (the “Agreement”) is made this 17th day of January, 2014 (the “Effective Date”), by and between Keryx Biopharmaceuticals, Inc. (“CUSTOMER”), a Delaware corporation having its principal office located at 750 Lexington Avenue, 20th Floor, New York, NY USA 10022, and Norwich Pharmaceuticals, Inc. (“NPI”; CUSTOMER and NPI are each a “Party” and are collectively the “Parties”), a Delaware corporation having its principal office at 6826 State Highway 12, Norwich, NY, USA 13815.
